Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Combination demonstrates deep PSA responses and favorable safety profile with plans to advance into Phase 3 Data highlight the potential of this first-in-class next-generation T-cell engager to expand
Johnson & Johnson $JNJ Shares Purchased by AlphaCore Capital LLC
03:13am, Thursday, 26'th Feb 2026
AlphaCore Capital LLC lifted its position in Johnson and Johnson (NYSE: JNJ) by 20.2% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Comm
Are You Looking for a High-Growth Dividend Stock?
12:45pm, Wednesday, 25'th Feb 2026
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Can J&J Sustain Its Double-Digit Oncology Growth Streak?
09:50am, Wednesday, 25'th Feb 2026
Johnson & Johnson JNJ is one of the key pharmaceutical players in the oncology segment with significant expertise in blood cancers and solid tumors. It is the #1 company in multiple myeloma, with key
Johnson & Johnson $JNJ Shares Bought by Empirical Asset Management LLC
05:06am, Wednesday, 25'th Feb 2026
Empirical Asset Management LLC grew its holdings in Johnson and Johnson (NYSE: JNJ) by 80.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchan
Market Today: AMD--Meta AI pact, WBD bid war, Stripe at $159B
05:35pm, Tuesday, 24'th Feb 2026
Guru Stock PicksPaul Singer has made the following transactions:Reduce in LUV by 8.86%Stock News Meta taps AMD for AI buildout: Meta Platforms (META) signed a m
Boring Is Beautiful: Why Johnson & Johnson Is Beating the Tech Sector
04:37pm, Tuesday, 24'th Feb 2026
While the technology sector faces a renewed wave of volatility driven by artificial intelligence (AI) scare trades and valuation concerns, a different story is unfolding in the healthcare sector. Inve
Data from the pivotal ENERGY trial showed IMAAVY® produced a rapid and durable hemoglobin responsea in wAIHA Currently no FDA-approved therapies are available for wAIHA, a rare, heterogeneous, life-t
Wall Street Bulls Look Optimistic About Johnson & Johnson (JNJ): Should You Buy?
10:30am, Tuesday, 24'th Feb 2026
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
First Look: Gilead buys Arcellx; IBM sinks on AI; Bitcoin slides
07:37am, Tuesday, 24'th Feb 2026
Stock News Dimon warns on credit cycle: JPMorgan Chase (JPM) CEO Jamie Dimon cautioned that elevated asset prices and growing banking competition echo preâ200
Bayer Sues J&J Over 51% Claim
06:16am, Tuesday, 24'th Feb 2026
Bayer (BAYRY) is taking Johnson and Johnson (JNJ) to court, accusing the healthcare giant of overstating the survival benefit of its prostate cancer drug Erleada
Chase Investment Counsel Corp Buys New Position in Johnson & Johnson $JNJ
05:56am, Tuesday, 24'th Feb 2026
Chase Investment Counsel Corp purchased a new stake in Johnson and Johnson (NYSE: JNJ) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. T
Johnson & Johnson $JNJ Shares Purchased by Compound Planning Inc.
05:56am, Tuesday, 24'th Feb 2026
Compound Planning Inc. raised its position in Johnson and Johnson (NYSE: JNJ) by 15.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Gilead Sciences Expands Oncology Portfolio with Arcellx Acquisition
12:14pm, Monday, 23'rd Feb 2026
Gilead Sciences (GILD) is set to enhance its oncology and cell therapy capabilities by acquiring Arcellx (ACLX). This acquisition deepens their existing collabo
Does JNJ Stock Still Offer Value?
11:35am, Monday, 23'rd Feb 2026
Up 17% through February 2026, Johnson & Johnson stock (NYSE: JNJ) is riding a wave of momentum fueled by a "triple threat" of high-growth oncology sales, a massive MedTech rebound, and a surprise earn
